// App-Quantinova.ai

: Efficacy of the Hepcon System in Reducing Hemorrhagic and Thrombotic Complications in Antiphospholipid Syndrome Patients Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass

Researchers

Presenter

  • Michael Sheu

Principal Investigators

  • Wei Wei

  • Lauren M Granat

  • John Apostolakis

  • Patrick M Grady

  • Dana E. Angelini

Medical Centers

  • Department of Internal Medicine, Cleveland Clinic, Cleveland, OH

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

  • Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH

  • Perfusion Services, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH

  • Cardiothoracic Anesthesiology, Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

Biomarkers

  • Carboxypeptidase B1

  • Dipeptidyl peptidase 1

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Efficacy

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved